HETEROCYCLIC INHIBITORS OF MCT4 Russian patent published in 2022 - IPC C07D403/10 C07D403/14 C07D231/12 C07D403/04 C07D403/06 C07D401/06 C07D405/12 C07D409/04 C07D417/04 A61K31/415 A61K31/455 A61K31/4184 A61P19/02 A61P35/00 

Abstract RU 2771875 C2

FIELD: chemistry.

SUBSTANCE: invention relates to compounds of formula VII, where the values W, Y, L, n are defined in the claims.

EFFECT: compounds are useful in the treatment of MCT4 mediated diseases such as proliferative and inflammatory diseases.

12 cl, 30 tbl, 269 ex

Similar patents RU2771875C2

Title Year Author Number
SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES 2013
  • Blejk Dzhim
  • Chen Khojfen
  • Chikarelli Mark
  • Gaudino Dzhon
  • Gazzard Lyuis
  • Kintz Sem
  • Mor Pit
  • Robardzh Kirk
  • Shvarts Dzhejkob
  • Chzhou Ajkhe
RU2644947C2
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS 2014
  • Chen Khuejfen
  • Chu Yanyan
  • Do Stiven
  • Estrada Entoni
  • Khu Bajkhua
  • Kolesnikov Aleksandr
  • Lin Sinyuj
  • Lissikatos Dzhozef P.
  • Shor Daniel
  • Verma Vishal
  • Vang Lan
  • U Goshen
  • Yuen Po-Vaj
RU2675792C2
OXADIAZOLE-BASED CHANNEL INHIBITORS WITH TRANSIENT POTENTIAL 2019
  • Terrett, Dzhek Aleksander
  • Chen, Khuejfen
  • Konstantino-Forzhe, Lea
  • Larush-Gote, Robin
  • Lepisse, Lyus
  • Bome, Fransi
  • Deri, Marten
  • Gran-Metr, Shantal
  • Sturino, Klaudio
  • Volgraf, Metyu
  • Villemur, Eliziya
RU2818244C2
BICYCLIC DERIVATIVES, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, THEIR USING IN TREATMENT AND METHOD FOR TREATMENT OF MAMMALS BY THEIR USING 2002
  • Di Fabio Romano
  • Mikeli Fabritsio
  • Sehn-Deni Iv
RU2310655C2
SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS 2014
  • Bollu Venkataya
  • Brajtenbukher Dzhejms
  • Kaplan Alan
  • Lemus Robert
  • Lindstrom Endryu
  • Vikers Troj
  • Uilson Mark E.
  • Zapf Dzhejms
  • Vajnkhaus Majkl I.
RU2668073C2
PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS 2021
  • Song, Minsoo
  • Park, Ga Youn
  • Kang, Jihee
  • Lee, Eunhye
  • Park, Yoojin
  • Choi, Yujeong
  • Kim, Soong-Hyun
  • Ko, Eun Bi
  • Bae, Seri
  • Park, Jung-Sang
  • Cha, Daewon
  • Lee, Wonhyung
  • Joo, Min Sung
  • Yoon, Taeyoung
  • Doh, Hyounmie
  • Sung, Hyun Jung
  • Lee, Bo Ryeong
  • Kim, Yoonjung
RU2818954C1
INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 2002
  • Makk'Ju Dzhon Sidmon
  • Tehm Stiv Jik-Kaj
  • Klark Dzhejms Donald
  • Li Kehtrin Lin
  • Chen Likhren
  • Takker Paresh
  • Sum Fuk-Vakh
  • Benke Mark Leo
  • Khu Bajkhua
RU2337906C2
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USE THEREOF 2016
  • Jorand-Lebrun, Catherine
  • Lan, Ruoxi
  • Chen, Austin
  • Clark, Ryan C.
RU2743360C2
BRUTON'S TYROSINE KINASE INHIBITORS 2013
  • Bagirat Niala
  • Dominik Romir
  • Kennedi-Smit Dzhoshua
  • Lopez-Tapia Fransisko Khaver
  • Mertts Erik
  • Tsyao Tsi
  • So Sun-Sau
RU2619465C2
BICYCLIC UREA, THIOUREA, GUANIDINE AND CYANOHUANIDINE COMPOUNDS, USEFUL FOR THE TREATMENT OF PAIN 2013
  • Allen Shelli
  • Endryus Stiven Vejd
  • Blejk Dzhejms F.
  • Brandkhuber Barbara Dzh.
  • Khaas Yuliya
  • Tszyan Yujtun
  • Kerkher Timoti
  • Kolakovski Gabriel R.
  • Tomas Allen A.
  • Vinski Shannon L.
RU2664541C2

RU 2 771 875 C2

Authors

Parnell, Kenneth, Mark

Mccall, John, M.

Romero, Donna

Dates

2022-05-13Published

2017-12-12Filed